BURLINGTON, ON, May 3, 2023
/CNW/ - EcoSynthetix Inc. (TSX: ECO) ("EcoSynthetix" or the
"Company"), a renewable chemicals company that produces a
portfolio of commercially proven bio-based products, today
announced its financial and operational results for the three
months (Q1 2023) ended March 31,
2023. Financial references are in U.S. dollars unless
otherwise indicated.
Highlights
(Comparison periods in each case are the
three months ended March 31,
2022)
- Recorded net sales of $3.1
million in Q1 2023, down 28%, due to lower volumes of 37%
compared to the prior period, partially offset by a higher average
selling price which impacted sales by 9%
- Gross profit of $0.6 million in
Q1 2023, down 43%, due to lower volumes and higher manufacturing
costs, including $0.2 million higher
depreciation, partially offset by a higher average selling
price
- Recorded an Adjusted EBITDA1 loss of $0.6 million in Q1 2023, an increase in loss of
$0.4 million from the prior
period
- Purchased and cancelled 68,400 common shares in Q1 2023 under
the normal course issuer bid for total consideration of
$0.2 million
- Maintained a strong balance sheet with cash and term deposits
of $35.6 million as at March 31, 2023
- A particleboard manufacturer, that is backward integrated into
a leading international retailer, identified the use of bio-based
glues as a key enabler to achieving their climate targets and
committed to a meaningful step in its implementation of DuraBindâ„¢
resin
- Announced improvements to the Company's asset bases in
North America and Europe, including internalizing 30 million
pounds of annualized nameplate manufacturing capacity at its Centre
of Innovation in Burlington,
Ontario
- Received the Platinum designation for the second consecutive
year from EcoVadis, a globally recognized agency for business
sustainability ratings of supply chains, by scoring within the top
1% of the 90,000 companies rated
"Despite disappointing results and challenging market conditions
to date this year, our pipeline of prospects continues to expand,
particularly in wood composites and our wet end strength aids,"
said Jeff MacDonald, CEO of
EcoSynthetix. "These opportunities and the size of the markets they
serve continue to give us confidence that we are working with the
right accounts to achieve our mid-term goal of $100 million in revenue. During the quarter, a
key strategic account that manufactures wood composites and is
backward integrated into a leading retailer committed to move
to bio-based glues in their wood panel production as one of the key
drivers to address their carbon footprint goals published in their
FY2022 Climate Report. This initiative included a meaningful step
in its implementation of our DuraBindâ„¢ resin. Expanding with this
account and other wood composites manufacturers in their supply
chain is a key growth driver. While macro challenges persist with a
soft start to Q2, our revenue diversification strategy with a
greater focus on wood composites, personal care and strength aids
for tissue and paperboard is the right approach to achieving our
growth plans."
Financial Summary
Net Sales
Net sales were $3.1 million for Q1
2023, compared to $4.2 million for
the same period in 2022. The 28% decrease was due to lower volumes
which impacted sales by $1.6 million
or 37%, which was partly offset by a higher average selling price
which impacted sales by $0.4 million,
or 9%. The lower volumes were due to several headwinds in Q1 2023
which resulted in a step down in demand due to the macroeconomic
challenges across many end markets, including approximately
$0.7 million lower sales due to
inventory destocking at a large distributor into the graphic paper
end market, continued demand deterioration in the graphic paper end
market, and softer demand due to market related customer mill
downtimes. The higher average selling price was due to the
offsetting of significant inflationary pressures with price
increases.
Gross Profit
Gross profit was $0.6 million for
Q1 2023, compared to $1.1 million for
the same period in 2022. The change was primarily due to a decrease
in sales volumes and higher costs of manufacturing partially offset
by a higher average selling price. Manufacturing costs also
included $0.2 million in additional
depreciation on certain machinery and equipment due to a change in
useful life as a result of the Company's plans to internalize its
North America Manufacturing.
Gross profit as a percentage of sales was 20.1% for Q1 2023,
compared to 25.5% for the same period in 2022. The change was
primarily due to higher manufacturing costs, partially offset by a
higher average selling price. Gross profit as a percentage of sales
adjusted for manufacturing depreciation was 32.6% for Q1 2023,
compared to 28.9% for the same period in 2022. The improvement was
due to a higher average selling price partially offset by higher
costs of manufacturing.
Selling, General and Administrative
Selling, general and administrative expenses (SG&A) were
$1.3 million, relatively unchanged
from the same period in 2022. Lower discretionary spending during
the period reduced SG&A expense by 90 thousand in absolute
terms.
Research and Development
Research and development (R&D) costs were $0.6 million for Q1 2023, compared to
$0.4 million in the same period in
2022. The increase was a result of increased discretionary
spending. R&D expense as a percentage of sales was 20% for Q1
2023, compared to 10% for the same period in 2022. The Company's
R&D efforts continue to focus on further enhancing value for
our existing products and expanding addressable opportunities.
Adjusted EBITDA1
Adjusted EBITDA loss was $0.6
million for Q1 2023, compared to $0.2
million in the same period in 2022. The increase in
loss was primarily due to lower gross profit and higher operating
costs when compared to the prior period.
Net
Loss
Net loss was $1.0 million, or
$0.02 per common share, for Q1 2023,
compared to $0.7 million, or
$0.01 per common share, for the same
period in 2022. The increase was due to a $0.5 million higher loss from operations
partially offset by an increase of $0.2
million in net interest income. The higher net interest
income is due to an increase in interest rates on cash and term
deposits.
Liquidity
Cash on hand and term deposits were $35.6
million as at March 31, 2023
compared to $36.0 million as at
December 31, 2022. The $0.4 million change was primarily due to
$0.4 million of cash used to purchase
property, plant, and equipment related to the Company's
manufacturing capacity realignment strategy and the $0.2 million for the purchase shares through the
normal course issuer bid ("NCIB"), partially offset by $0.3 million cash-flow from operations. The
Company purchased and cancelled 68,400 common shares under the NCIB
during Q1 2023.
Notice of Conference Call
EcoSynthetix will host a conference call Thursday, May 4, 2023, at 8:30 AM ET to discuss its financial results.
Jeff MacDonald, CEO, and
Robert Haire, CFO, will co-chair the
call. All interested parties can instantly join the call by phone,
by following the URL https://emportal.ink/3nWR2Ir to easily
register and be connected into the conference call automatically or
the conventional method by dialling (416) 764-8659 or (888)
664-6392 with the conference identification of 18511532. Please
dial in 15 minutes prior to the call to secure a line. A live audio
webcast of the conference call will also be available at
www.ecosynthetix.com or https://app.webinar.net/7NXQK4XKxV0. The
presentation will be accompanied by slides, which will be available
via the webcast link and the Company's website. Please connect at
least 15 minutes prior to the conference call to ensure adequate
time for any software download that may be required to join the
webcast.
1Non-IFRS Financial Measures
This press release makes reference to certain non-IFRS measures.
These non-IFRS measures are not recognized measures under IFRS, do
not have a standardized meaning prescribed by IFRS and are
therefore unlikely to be comparable to similar measures presented
by other companies. Rather, these measures are provided as
additional information to complement those IFRS measures by
providing a further understanding of results of operations of
EcoSynthetix from management's perspective. Accordingly, they
should not be considered in isolation nor as a substitute for
analysis of the financial information of EcoSynthetix reported
under IFRS. The Company uses non-IFRS measures such as Adjusted
EBITDA to provide investors with a supplemental measure of
operating performance and thus highlight trends in its core
business that may not otherwise be apparent when relying solely on
IFRS financial measures. Management also believes that securities
analysts, investors and other interested parties frequently use
non-IFRS measures in the evaluation of issuers. Management also
uses non-IFRS measures in order to facilitate operating performance
comparisons from period to period, prepare annual operating budgets
and assess the Company's ability to meet its capital expenditure
and working capital requirements.
Adjusted EBITDA is not a measure recognized under IFRS and does
not have a standardized meaning prescribed by IFRS. See "IFRS and
Non-IFRS Measures." The Company presents Adjusted EBITDA because
the Company believes it facilitates investors' use of operating
performance comparisons from period to period and company to
company by backing out potential differences caused by variations
in capital structures (affecting relative interest expense), the
book amortization of intangibles (affecting relative amortization
expense) and the age and book value of property and equipment
(affecting relative depreciation expense). The Company also
presents Adjusted EBITDA because it believes it is frequently used
by securities analysts, investors and other interested parties as a
measure of financial performance. Adjusted EBITDA as presented
herein are not recognized measures under IFRS and should not be
considered as an alternative to operating income or net income as
measures of operating results or an alternative to cash flows as
measures of liquidity. Adjusted EBITDA is defined as consolidated
net income (loss) before net interest expense, income taxes,
depreciation, amortization, other non-cash expenses and charges
deducted in determining consolidated net income (loss).
The following table reconciles net loss to Adjusted EBITDA loss
for the three months ended March 31,
2023, and March 31, 2022:
|
Three months
ended
March 31, 2023
|
Three months
ended
March 31, 2022
|
Net
Loss
|
(988,255)
|
(658,892)
|
Depreciation
|
487,894
|
232,552
|
Share-based
Compensation
|
163,632
|
271,966
|
Interest
Income
|
(250,806)
|
(32,487)
|
Adjusted EBITDA
loss
|
(587,535)
|
(186,861)
|
About EcoSynthetix Inc. (www.ecosynthetix.com)
EcoSynthetix offers a range of sustainable engineered
biopolymers that allow customers to reduce their use of harmful
materials, such as formaldehyde and styrene-based chemicals. The
Company's flagship products, DuraBindâ„¢, Surflockâ„¢, Bioformâ„¢, and
EcoSphere®, are used to manufacture wood composites, personal care,
paper, tissue and packaging products, and enable performance
improvements, economic benefits and carbon footprint reduction. The
Company is publicly traded on the Toronto Stock Exchange
(T:ECO).
Forward-Looking Statements
Certain statements in this Press Release constitute
"forward-looking" statements that involve known and unknown risks,
uncertainties and other factors which may cause the actual results,
performance, objectives or achievements of the Company, or industry
results, to be materially different from any future results,
performance, objectives or achievements expressed or implied by
such forward looking statements. The forward-looking statements in
this Press Release include, but are not limited to, statements
regarding the Company's plans to execute its commercial strategy,
deliver meaningful growth across all three product categories,
convert high-value strategic prospects into customers, and other
statements regarding the Company's plans and expectations in 2023.
These statements reflect our current views regarding future events
and operating performance and are based on information currently
available to us, and speak only as of the date of this Press
Release. These forward-looking statements involve a number of
risks, uncertainties and assumptions and should not be read as
guarantees of future performance or results, and will not
necessarily be accurate indications of whether or not such
performance or results will be achieved. Those assumptions and
risks include, but are not limited to, the Company's ability to
successfully allocate capital as needed and to develop new
products, as well as the fact that our results of operations and
business outlook are subject to significant risk, volatility and
uncertainty. Many factors could cause our actual results,
performance or achievements to be materially different from any
future results, performance or achievements that may be expressed
or implied by such forward-looking statements, including the
factors identified in the "Risk Factors" section of the Company's
Annual Information Form dated February 28,
2023. Should one or more of these risks or uncertainties
materialize, or should assumptions underlying the forward-looking
statements prove incorrect, actual results may vary materially from
those described in this Press Release as intended, planned,
anticipated, believed, estimated or expected. Unless required by
applicable securities law, we do not intend and do not assume any
obligation to update these forward-looking statements.
EcoSynthetix
Inc.
|
|
|
Interim Consolidated
Balance Sheets
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
|
March 31,
2023
|
December 31,
2022
|
Assets
|
|
|
|
|
|
Current
assets
|
|
|
Cash
|
5,713,651
|
4,808,606
|
Term
deposits
|
29,913,232
|
21,054,812
|
Accounts
receivable
|
1,302,845
|
2,912,000
|
Inventory
|
5,019,523
|
5,317,367
|
Government grants
receivable
|
42,733
|
18,386
|
Prepaid
expenses
|
97,950
|
85,131
|
|
42,089,934
|
34,196,302
|
|
|
|
Non-current
assets
|
|
|
Term
deposits
|
-
|
10,138,542
|
Property, plant and
equipment
|
3,797,768
|
3,859,413
|
|
3,797,768
|
13,997,955
|
|
|
|
Total
assets
|
45,887,702
|
48,194,257
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
Current
liabilities
|
|
|
Trade accounts payables
and accrued liabilities
|
1,319,605
|
2,595,353
|
|
|
|
Non-current
liabilities
|
|
|
Lease
liability
|
494,554
|
543,639
|
|
|
|
Total
liabilities
|
1,814,159
|
3,138,992
|
Shareholders'
Equity
|
|
|
Common
shares
|
491,555,432
|
491,700,059
|
Contributed
surplus
|
10,232,616
|
10,081,456
|
Accumulated
deficit
|
(457,714,505)
|
(456,726,250)
|
Total shareholders'
equity
|
44,073,543
|
45,055,265
|
|
|
|
Total liabilities
and shareholders' equity
|
45,887,702
|
48,194,257
|
EcoSynthetix
Inc.
|
|
|
Interim Consolidated
Statements of Operations and Comprehensive Loss
|
|
|
For the three months
ended March 31, 2023 and 2022
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
Three months
ended March 31,
|
|
2023
|
2022
|
|
|
|
Net
sales
|
3,061,508
|
4,237,955
|
|
|
|
Cost of
sales
|
2,445,585
|
3,157,915
|
|
|
|
Gross profit on
sales
|
615,923
|
1,080,040
|
|
|
|
Expenses
|
|
|
Selling, general and
administrative
|
1,250,174
|
1,340,685
|
Research and
development
|
604,810
|
430,734
|
|
1,854,984
|
1,771,419
|
|
|
|
Loss from
operations
|
(1,239,061)
|
(691,379)
|
|
|
|
Net interest
income
|
250,806
|
32,487
|
Net loss and
comprehensive loss
|
(988,255)
|
(658,892)
|
|
|
|
Basic and diluted
loss per common share
|
(0.02)
|
(0.01)
|
Weighted average
number of common shares outstanding
|
59,269,038
|
58,913,708
|
EcoSynthetix
Inc.
|
|
|
Interim Consolidated
Statements of Cash Flows
|
|
|
For the three months
ended March 31, 2023 and 2022
|
|
|
(expressed in US
dollars)
|
|
|
|
|
|
|
|
|
Three months
ended March 31,
|
|
2023
|
2022
|
Cash provided by
(used in)
|
|
|
|
|
|
Operating
activities
|
|
|
Net loss and
comprehensive loss
|
(988,255)
|
(658,892)
|
Items not affecting
cash
|
|
|
Depreciation
|
487,894
|
232,552
|
Share-based
compensation
|
163,632
|
271,966
|
Other
|
12,167
|
(48,177)
|
Changes in non-cash
working capital
|
|
|
Accounts
receivable
|
1,609,155
|
8,809
|
Inventory
|
296,077
|
(805,986)
|
Government grants
receivable
|
(24,347)
|
(6,720)
|
Prepaid expenses
|
(12,819)
|
45,075
|
Trade accounts payables and
accrued liabilities
|
(1,298,372)
|
(654,127)
|
Interest on term
deposits
|
|
|
Interest received on term deposits
|
266,017
|
-
|
Accrued interest on term deposits
|
(219,280)
|
(45,937)
|
|
291,869
|
(1,661,437)
|
|
|
|
Investing
activities
|
|
|
Purchase of property,
plant and equipment
|
(380,900)
|
(49,562)
|
Receipts on mature term
deposits
|
6,534,444
|
-
|
Purchase of term
deposits
|
(5,300,000)
|
(20,000,000)
|
|
853,544
|
(20,049,562)
|
|
|
|
Financing
activities
|
|
|
Payments made on lease
liability
|
(70,584)
|
(61,281)
|
Common shares
repurchased
|
(183,966)
|
(613,613)
|
Exercise of common
share options
|
26,867
|
-
|
|
(227,683)
|
(674,894)
|
|
|
|
|
|
|
Effect of exchange rate
changes on cash
|
(12,685)
|
62,536
|
|
|
|
Change in cash
during the period
|
905,045
|
(22,323,357)
|
|
|
|
Cash - Beginning of
period
|
4,808,606
|
42,226,816
|
|
|
|
Cash - End of
period
|
5,713,651
|
19,903,459
|
SOURCE EcoSynthetix Inc.